Skip to main content
VIVS
NASDAQ Life Sciences

VivoSim Seeks Approval for Reverse Split, Equity Plan Increase, and Warrant Share Issuance

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Biotech Stocks · Healthcare
Sentiment info
Negative
Importance info
8
Price
$0.286
Mkt Cap
$4.744M
52W Low
$0.263
52W High
$5.3
52W Position info
9.0% above low
Off High info
95% below high
Rel. Volume info
0.1× avg
Market data snapshot near publication time

VIVS is trading near its 52-week low of $0.263 (9.0% above the low) on light trading volume (0.1× avg).

Summary

VivoSim's definitive proxy sets a September 30 vote on a reverse split, a 3.165M share equity plan increase, and issuance of 4.7M warrant shares with a reduced exercise price.


Key Events · Corporate Governance and Compliance · VIVS

  • Reverse Stock Split Vote

    Stockholders will vote on a reverse split at a ratio between 1-for-5 and 1-for-20, with the board authorized to implement it any time before September 30, 2027. At 1-for-20, outstanding shares would drop from 16.6M to about 829,000.

  • Equity Plan Share Increase

    Proposal 5 seeks to add 3,165,000 shares to the 2022 Equity Incentive Plan, representing about 19% of current outstanding shares. The company says the reserve is expected to last four years.

  • Warrant Share Issuance and Repricing

    Proposal 6 asks approval for 4,705,883 common warrant shares and a reduction of the May 2024 Investor Warrant exercise price from $9.60 to $0.85. Full exercise would dilute existing holders by approximately 23.85%.

  • Nasdaq Compliance Context

    The warrant proposal is required by Nasdaq Listing Rule 5635(d) and the July 2026 PIPE terms. The company regained Nasdaq compliance in August 2026 after a delisting notice in July.


Analysis · VIVS · Life Sciences

The definitive proxy for the September 30 annual meeting adds two material proposals beyond the reverse stock split already previewed in the preliminary filing: a 3.165 million share increase to the equity incentive plan and approval for 4.7 million warrant shares plus a warrant exercise price reduction from $9.60 to $0.85. The warrant proposal is required by Nasdaq rules and the July 2026 PIPE terms; if approved, it would dilute existing holders by roughly 23.85%. The reverse split, if enacted at up to 1-for-20, would shrink the share count from 16.6 million to as low as 829,000, boosting the per-share price but leaving authorized shares unchanged, creating significant future issuance headroom. These votes are pivotal for the company's capital structure and Nasdaq compliance.

How filings like this one have moved

In the 30 days to Nov 17, 2026, 48.3% of the 2133 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.28%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, VIVS was trading at $0.29 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $4.7M. The 52-week trading range was $0.26 to $5.30. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

VIVS - Latest Insights

VIVS
Nov 19, 2026, 8:05 AM EST
Source: Wiseek News
Importance Score:
7
Price at Filing: $0.1536
Real-time Price: $0.242811 info
Change: +$0.089211 (+58%) info
Market Cap: $5.289M info
VIVS
Nov 12, 2026, 4:06 PM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $0.1342
Real-time Price: $0.242811 info
Change: +$0.108611 (+81%) info
Market Cap: $5.289M info
VIVS
Oct 06, 2026, 4:05 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.2019
Real-time Price: $0.242811 info
Change: +$0.040911 (+20%) info
Market Cap: $5.289M info
VIVS
Sep 16, 2026, 8:05 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $0.3067
Real-time Price: $0.242811 info
Change: -$0.063889 (-21%) info
Market Cap: $5.289M info
VIVS
Aug 21, 2026, 4:05 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $0.286
Real-time Price: $0.242811 info
Change: -$0.043189 (-15%) info
Market Cap: $5.289M info